findmyKOL

Andrew Defilippis, MD

Basic profile

Vanderbilt University Medical Center

ORCIDNPI
RegionNashville, TN · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH funding2021–2025

Andrew Defilippis is a Cardiology physician affiliated with Vanderbilt University Medical Center. OpenAlex indexes 241 publications with 10,644 citations (h-index 54).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
241publications

Distinct works indexed by OpenAlex, matched via ORCID.

10,644citations

Total citations across indexed works.

54h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2021–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3601 The Vanderbilt Clinic
Nashville, TN 372325703

Telephone

615-936-2000

Provider last certified this registry record 2 Jun 2026.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    69.6%
    Statin46.1%
    Atorvastatin Calcium60%Rosuvastatin Calcium40%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)11.8%
    Losartan Potassium100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    16.7%
    SGLT2 inhibitor16.7%
    Jardiance100%
    Part D<11 patients
  • Blood & clotting

    13.7%
    Factor Xa inhibitor13.7%
    Eliquis100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20212025 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”